Tech-2454: Profitable Microbial Laboratory Service Provider/CRO in the Midwest. The laboratory offers microbiology services specializing in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded by pharmaceutical industry infectious disease scientists, the company is a unique contract research organization that offers clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics. Each client has a customized relationship and can have a stand-alone assay service or collaborative discovery program for exploratory projects. As a long-standing provider of these type of services, the company is well known and respected in the various areas served and enjoys a strong history of repeat business. The current founding owner is now ready to transition the company to a new owner who will continue the service and quality developed over the past 14 years. A unique opportunity to acquire a strong company with a solid history and reputation. Seller will consider all proposals for merger or acquisition. Gross Revenue previous 12 months $1.9 million, Average EBITDA past four years $450K, Asking Price $2.5M
